Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas M Werge

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Medrxiv : the Preprint Server for Health Sciences|March 11, 2024
Quantifying the Relative Importance of Genetics and Environment on the Comorbidity between Mental- and Cardiometabolic Disorders: A Comprehensive Analysis of National Register Data from 17 million ScandinaviansJoeri Meijsen, Kejia Hu, Morten Dybdahl Krebs, et al.
Nature Neuroscience|November 27, 2019
Autism spectrum disorder and attention deficit hyperactivity disorder have a similar burden of rare protein-truncating variantsF Kyle Satterstrom, Raymond K Walters, Tarjinder Singh, et al.
Nature Communications|June 13, 2024
Quantifying the relative importance of genetics and environment on the comorbidity between mental and cardiometabolic disorders using 17 million ScandinaviansJoeri Meijsen, Kejia Hu, Morten D Krebs, et al.
The Lancet. Psychiatry|June 11, 2017
Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trialAnne Katrine Pagsberg, Pia Jeppesen, Dea Gowers Klauber, et al.
Nature Genetics|November 30, 2023
Polygenic profiles define aspects of clinical heterogeneity in attention deficit hyperactivity disorderSonja LaBianca, Isabell Brikell, Dorte Helenius, et al.
Nature Genetics|November 13, 2025
Genome-wide association analyses identify distinct genetic architectures for early-onset and late-onset depressionJohn R Shorter, Joëlle A Pasman, Siim Kurvits, et al.
BMC Psychiatry|July 13, 2014
Quetiapine versus aripiprazole in children and adolescents with psychosis--protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trialAnne Katrine Pagsberg, Pia Jeppesen, Dea Gowers Klauber, et al.
Medrxiv : the Preprint Server for Health Sciences|August 12, 2025
Genome-wide study of somatic symptom and related disorders identifies novel genomic loci and map genetic architectureVera Fominykh, Piotr Jaholkowski, Alexey A Shadrin, et al.
Plos Genetics|May 7, 2016
Parental Origin of Interstitial Duplications at 15q11.2-q13.3 in Schizophrenia and Neurodevelopmental DisordersAnthony R Isles, Andrés Ingason, Chelsea Lowther, et al.
Medrxiv : the Preprint Server for Health Sciences|September 26, 2025
The genetic architecture of fibromyalgia across 2.5 million individualsIsabel Kerrebijn, Gyda Bjornsdottir, Keon Arbabi, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Medrxiv : the Preprint Server for Health Sciences|March 11, 2024
Quantifying the Relative Importance of Genetics and Environment on the Comorbidity between Mental- and Cardiometabolic Disorders: A Comprehensive Analysis of National Register Data from 17 million ScandinaviansJoeri Meijsen, Kejia Hu, Morten Dybdahl Krebs, et al.
Nature Neuroscience|November 27, 2019
Autism spectrum disorder and attention deficit hyperactivity disorder have a similar burden of rare protein-truncating variantsF Kyle Satterstrom, Raymond K Walters, Tarjinder Singh, et al.
Nature Communications|June 13, 2024
Quantifying the relative importance of genetics and environment on the comorbidity between mental and cardiometabolic disorders using 17 million ScandinaviansJoeri Meijsen, Kejia Hu, Morten D Krebs, et al.
The Lancet. Psychiatry|June 11, 2017
Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trialAnne Katrine Pagsberg, Pia Jeppesen, Dea Gowers Klauber, et al.
Nature Genetics|November 30, 2023
Polygenic profiles define aspects of clinical heterogeneity in attention deficit hyperactivity disorderSonja LaBianca, Isabell Brikell, Dorte Helenius, et al.
Nature Genetics|November 13, 2025
Genome-wide association analyses identify distinct genetic architectures for early-onset and late-onset depressionJohn R Shorter, Joëlle A Pasman, Siim Kurvits, et al.
BMC Psychiatry|July 13, 2014
Quetiapine versus aripiprazole in children and adolescents with psychosis--protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trialAnne Katrine Pagsberg, Pia Jeppesen, Dea Gowers Klauber, et al.
Medrxiv : the Preprint Server for Health Sciences|August 12, 2025
Genome-wide study of somatic symptom and related disorders identifies novel genomic loci and map genetic architectureVera Fominykh, Piotr Jaholkowski, Alexey A Shadrin, et al.
Plos Genetics|May 7, 2016
Parental Origin of Interstitial Duplications at 15q11.2-q13.3 in Schizophrenia and Neurodevelopmental DisordersAnthony R Isles, Andrés Ingason, Chelsea Lowther, et al.
Medrxiv : the Preprint Server for Health Sciences|September 26, 2025
The genetic architecture of fibromyalgia across 2.5 million individualsIsabel Kerrebijn, Gyda Bjornsdottir, Keon Arbabi, et al.
Pageof 4